Cita APA (7a ed.)

Yaxley, W. J., McBean, R., Wong, D., Grimes, D., Vasey, P., Frydenberg, M., & Yaxley, J. W. (2021). Should Lutetium-prostate specific membrane antigen radioligand therapy for metastatic prostate cancer be used earlier in men with lymph node only metastatic prostate cancer? Korean Urological Association.

Cita Chicago Style (17a ed.)

Yaxley, William John, Rhiannon McBean, David Wong, David Grimes, Paul Vasey, Mark Frydenberg, y John William Yaxley. Should Lutetium-prostate Specific Membrane Antigen Radioligand Therapy for Metastatic Prostate Cancer Be Used Earlier in Men with Lymph Node Only Metastatic Prostate Cancer? Korean Urological Association, 2021.

Cita MLA (8a ed.)

Yaxley, William John, et al. Should Lutetium-prostate Specific Membrane Antigen Radioligand Therapy for Metastatic Prostate Cancer Be Used Earlier in Men with Lymph Node Only Metastatic Prostate Cancer? Korean Urological Association, 2021.

Precaución: Estas citas no son 100% exactas.